- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                                    FORM 10-Q


             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended March 31, 2002
                                                 --------------

                         Commission File Number 0-19294
                                                -------


                              REHABCARE GROUP, INC.
                              ---------------------
             (Exact name of Registrant as specified in its charter)

          Delaware                                    51-0265872
- -------------------------------         ---------------------------------------
(State or other jurisdiction of         (I.R.S. Employer Identification Number)
incorporation or organization)


             7733 Forsyth Boulevard, Suite 1700, St. Louis, MO 63105
             -------------------------------------------------------
              (Address of principal executive offices and zip code)

                                  314-863-7422
             -------------------------------------------------------
              (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                       Yes    X                 No
                           -------                 -------

Indicate the number of shares  outstanding of the Registrant's  common stock, as
of the latest practicable date.


                Class                             Outstanding at May 9, 2002
- --------------------------------------            ----------------------------
Common Stock, par value $.01 per share                    17,374,513


- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                                    1 of 16




                              REHABCARE GROUP, INC.

                                      Index



Part I. - Financial Information

   Item 1. - Condensed Consolidated Financial Statements

      Condensed consolidated balance sheets,
        March 31, 2002 (unaudited) and December 31, 2001                   3

      Condensed consolidated statements of earnings for the three
        months ended March 31, 2002 and 2001 (unaudited)                   4

      Condensed consolidated statements of cash flows for the
        three months ended March 31, 2002 and 2001(unaudited)              5

      Notes to condensed consolidated financial statements (unaudited)     6

   Item 2. - Management's Discussion and Analysis of Financial
      Condition and Results of Operations                                 10

Part II. - Other Information

   Item 1. - Legal Proceedings                                            13

   Item 4. - Submission of Matters to Security Holders                    14

   Item 6. - Exhibits and Reports on Form 8-K                             15

   Signatures                                                             16

                                    2 of 16



PART 1. - FINANCIAL INFORMATION
Item 1. - Condensed Consolidated Financial Statements
- -----------------------------------------------------


                              REHABCARE GROUP, INC.
                      Condensed Consolidated Balance Sheets
                  (dollars in thousands, except per share data)


                                                       March 31,   December 31,
                                                         2002         2001
                                                         ----         ----
                                                             
                  Assets                              (unaudited)
                  ------
Current assets:
    Cash and cash equivalents                         $ 26,468     $ 18,534
    Marketable securities, available-for-sale               25        1,025
    Accounts receivable, net of allowance for doubtful
      accounts of $6,429 and $5,902, respectively       88,298       91,384
    Income taxes receivable                                 --        2,055
    Deferred tax assets                                  9,713        7,658
    Prepaid expenses and other current assets            2,633        2,390
                                                       -------      -------
      Total current assets                             127,137      123,046
Marketable securities, trading                           3,038        2,870
Equipment and leasehold improvements, net               20,056       18,373
Excess of cost over net assets acquired, net           101,685      101,685
Other                                                    4,983        4,687
                                                       -------      -------
   Total assets                                       $256,899     $250,661
                                                       =======      =======


         Liabilities and Stockholders' Equity
         ------------------------------------
Current liabilities:
    Accounts payable                                  $  2,768      $ 3,567
    Accrued salaries and wages                          27,887       27,141
    Accrued expenses                                    14,164       14,814
    Income taxes payable                                 2,367           --
                                                       -------      -------
      Total current liabilities                         47,186       45,522
Deferred compensation and other long-term
   liabilities                                           3,233        3,043
Deferred tax liabilities                                 2,976        3,060
                                                       -------      -------
      Total liabilities                                 53,395       51,625
                                                       -------      -------
Stockholders' equity:
   Preferred stock, $.10 par value, authorized
      10,000,000 shares, none issued and outstanding        --           --
    Common stock, $.01 par value; authorized 60,000,000
      shares, issued 19,641,129 shares and 19,631,789
      shares as of March 31, 2002 and December 31,
      2001, respectively                                   197          196
    Additional paid-in capital                         109,961      109,522
    Retained earnings                                  111,085      107,057
    Less common stock held in treasury at cost,
      2,302,898 shares as of March 31, 2002 and
      December 31, 2001                                (17,757)     (17,757)
    Accumulated other comprehensive earnings                18           18
                                                       -------      -------
      Total stockholders' equity                       203,504      199,036
                                                       -------      -------
                                                      $256,899     $250,661
                                                       =======      =======


      See accompanying notes to condensed consolidated financial statements.

                                    3 of 16




                              REHABCARE GROUP, INC.
                  Condensed Consolidated Statements of Earnings
                  (amounts in thousands, except per share data)
                                   (Unaudited)


                                                        Three Months Ended
                                                              March 31,
                                                           2002    2001
                                                           ----    ----
                                                               
Operating revenues                                      $138,229  $130,724
Costs and expenses:
   Operating expenses                                    102,826    93,033
   General and administrative                             26,926    22,527
   Depreciation and amortization                           1,925     2,122
                                                         -------   -------
     Total costs and expenses                            131,677   117,682
                                                         -------   -------
     Operating earnings                                    6,552    13,042
Interest income                                              106        62
Interest expense                                            (165)   (1,186)
Other income                                                   3         9
                                                         -------   -------
Earnings before income taxes                               6,496    11,927
Income taxes                                               2,468     4,749
                                                         -------   -------
     Net earnings                                       $  4,028  $  7,178
                                                         =======   =======

Net earnings per common share:
     Basic                                              $   0.23  $   0.47
                                                         =======   =======
     Diluted                                            $   0.22  $   0.42
                                                         =======   =======
Weighted-average number of
   common shares outstanding:
     Basic                                                17,338    15,434
                                                         =======   =======
     Diluted                                              18,211    17,014
                                                         =======   =======

     See accompanying notes to condensed consolidated financial statements.

                                    4 of 16





                              REHABCARE GROUP, INC.
                 Condensed Consolidated Statements of Cash Flows
                             (dollars in thousands)
                                   (Unaudited)

                                                            Three Months Ended
                                                                 March 31,
                                                             2002       2001
                                                             ----       ----
                                                                 
Cash flows from operating activities:
   Net earnings                                          $  4,028   $  7,178
   Adjustments to reconcile net earnings to net
     cash provided by operating activities:
        Depreciation and amortization                       1,925      2,122
        Provision for doubtful accounts                     1,102        929
        Income tax benefit realized on employee
           stock option exercises                             171      4,001
        Change in assets and liabilities:
           Accounts receivable, net                         1,984     (5,901)
           Prepaid expenses and other current assets         (243)      (196)
           Other assets                                       130         (1)
           Accounts payable and accrued expenses           (1,449)       914
           Accrued salaries and wages                         746       (381)
           Deferred compensation                              190        491
           Income taxes                                     2,283      3,652
                                                          -------   --------
               Net cash provided by operating
               activities                                  10,867     12,808
                                                          -------   --------

Cash flows from investing activities:
   Additions to equipment and leasehold improvements, net  (3,311)    (2,668)
   Purchase of marketable securities                         (183)      (591)
   Proceeds from sale/maturities of marketable securities   1,015        109
   Other, net                                                (723)      (420)
                                                          -------   --------
               Net cash used in investing activities       (3,202)    (3,570)
                                                          -------   --------
Cash flows from financing activities:
   Proceeds from (repayments on) revolving credit
   facility, net                                               --    (60,100)
   Proceeds from sale of common stock, net                     --     49,581
   Exercise of stock options                                  269      2,097
                                                          -------   --------
               Net cash provided by (used in)
                  financing activities                        269     (8,422)
                                                          -------   --------
               Net increase in cash and cash
                  equivalents                               7,934        816
Cash and cash equivalents at beginning of period           18,534      7,942
                                                          -------   --------
Cash and cash equivalents at end of period               $ 26,468  $   8,758
                                                          =======   ========



     See accompanying notes to condensed consolidated financial statements.

                                    5 of 16




                              REHABCARE GROUP, INC.

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
              ----------------------------------------------------
                Three Month Periods Ended March 31, 2002 and 2001
                                   (Unaudited)

Note 1. - Basis of Presentation
- -------------------------------

     The   condensed   consolidated   balance   sheets  and  related   condensed
consolidated  statements of earnings and cash flows contained in this Form 10-Q,
which are  unaudited,  include the  accounts of the Company and its wholly owned
subsidiaries.  There are no other components of comprehensive  income other than
the Company's  consolidated net income for the three months ended March 31, 2002
and  2001.  All  significant   intercompany  accounts  and  activity  have  been
eliminated in consolidation. In the opinion of management, all entries necessary
for a fair presentation of such financial  statements have been included.  These
entries  consisted only of normal recurring items. The results of operations for
the three months ended March 31, 2002,  are not  necessarily  indicative  of the
results to be expected for the fiscal year. Certain prior year amounts have been
reclassified to conform with the current year presentation.

     The  condensed   consolidated  financial  statements  do  not  include  all
information  and footnotes  necessary for a complete  presentation  of financial
position,  results of operations  and cash flows in conformity  with  accounting
principles generally accepted in the United States of America. Reference is made
to the Company's audited consolidated financial statements and the related notes
as of  December  31,  2001 and 2000 and for each of the years in the  three-year
period ended  December 31, 2001,  included in the Annual  Report on Form 10-K on
file with the  Securities  and Exchange  Commission,  which  provide  additional
disclosures and a further description of the Company's accounting policies.

Note 2. - New Accounting Pronouncements
- ---------------------------------------

     In July 2001, the Financial  Accounting  Standards  Board  ("FASB")  issued
Statement of Financial  Accounting  Standards  ("Statement") No. 141,  "Business
Combinations,"  and Statement No. 142,  "Goodwill and Other Intangible  Assets."
Statement  No. 141 requires  that the purchase  method of accounting be used for
all business combinations initiated and completed after June 30, 2001. Statement
No. 141 also specifies certain criteria intangible assets acquired in a purchase
method business  combination  must meet to be recognized and reported apart from
goodwill.  Statement No. 142 requires that goodwill and  intangible  assets with
indefinite  useful  lives  no  longer  be  amortized,  but  instead  tested  for
impairment at least annually in accordance  with the provisions of Statement No.
142.  Statement  No. 142 also  requires that  intangible  assets with  estimable
useful lives be amortized over their respective  estimated useful lives to their
estimated  residual  values,  and reviewed for  impairment  in  accordance  with
Statement No. 121,  "Accounting for the Impairment of Long-Lived  Assets and for
Long-Lived  Assets to be Disposed  Of." The Company  adopted the  provisions  of
Statement  No.  141 in July 2001 and  Statement  No.  142 on  January  1,  2002.
Statement  No. 141 requires  that upon  adoption of  Statement  142, the Company
evaluate its existing intangible assets and goodwill that were acquired in prior
purchase business combinations,  and to make any necessary  reclassifications in
order to conform  with the new  criteria in  Statement  No. 141 for  recognition
apart from  goodwill.  Upon  adoption  of  Statement  No.  142,  the Company was
required to reassess  the useful  lives and  residual  values of all  intangible
assets acquired,  and make any necessary  amortization period adjustments by the
end of the first quarter of 2002. In addition, to the extent an intangible asset
is identified as having an indefinite life, the Company was required to test the
intangible  asset for impairment in accordance  with the provisions of Statement
No. 142 within the first  quarter of 2002.  The Company has tested  goodwill and
intangible assets for impairment under the provision of Statement No. 142. These
tests  indicated that there was no impairment of goodwill or intangible  assets.
As of the date of adoption,  the Company had unamortized  goodwill in the amount
of $101.7 million and unamortized identifiable intangible assets

                                    6 of 16



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
        ----------------------------------------------------------------

in the  amount of $0.1  million,  all of which  are  subject  to the  transition
provisions of Statement No. 141 and Statement No. 142.  Under the  provisions of
Statement  No. 142, for fiscal  years  beginning  after 2001,  the Company is no
longer recording amortization expense on goodwill.

     As of March 31, 2002,  the Company had the  following  acquired  intangible
assets recorded:

                                                     Gross         Accumulated
                                                Carrying Amount   Amortization
                                                ---------------   ------------
                                                        (in thousands)

Amortized Intangible Assets:
   Purchased contracts                                $100             $ 7

Purchased  contracts are being amortized  straight-line over the average life of
the contracts, which is 46 months.

The following  table  indicates the effect on net earnings and diluted  earnings
per  share if  Statement  No.  142 had  been in  effect  for  each of the  years
presented in the Condensed Consolidated Statement of Earnings:



                                                           Three Months Ended
                                                                March 31,
                                                            2002       2001
                                                            ----       ----
                                                  (in thousands, except per share data)
                                                                 
   Reported net earnings                                 $  4,028   $  7,178
   Add back: goodwill amortization, net of taxes               --        697
                                                          -------    -------
   Adjusted net earnings                                 $  4,028   $  7,875
                                                          =======    =======

   Basic net earnings per share:
   As reported                                           $   0.23   $   0.47
   Add back: goodwill amortization, net of taxes               --       0.04
                                                          -------    -------
   Adjusted basic net earnings per share                 $   0.23   $   0.51
                                                          =======    =======


   Diluted net earnings per share:
   As reported                                           $   0.22   $   0.42
   Add back: goodwill amortization, net of taxes               --       0.04
                                                          -------    -------
   Adjusted diluted net earnings per share               $   0.22   $   0.46
                                                          =======    =======


     In October  2001,  the FASB issued  Statement No. 144  "Accounting  for the
Impairment or Disposal of Long-Lived Assets" which supersedes  Statement No. 121
"Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to
be Disposed Of." Statement No. 144 also  supersedes the accounting and reporting
provisions of APB Opinion No. 30 "Reporting the Results of  Operations-Reporting
the Effects of Disposal of a Segment of a Business,  and Extraordinary,  Unusual
and  Infrequently  Occurring  Events  and  Transactions."  Statement  No. 144 is
intended to establish one accounting model for long-lived  assets to be disposed
of by sale and to address significant implementation issues. The Company adopted
Statement  No.  144 on  January  1,  2002.  The  adoption  had no  effect on the
condensed consolidated financial statements.


                                    7 of 16


REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
        ----------------------------------------------------------------


Note 3. - Net earnings per share
- --------------------------------

The following table sets forth the computation of basic and diluted net earnings
per share:


                                                      Three Months Ended
                                                           March 31,
                                                      2002           2001
                                                      ----           ----
                                              (in thousands, except per share data)
                                                               
Numerator:

Numerator for basic/diluted net earnings
   per share - net earnings available
   to common stockholders after
   assumed conversions                             $  4,028      $   7,178
                                                    =======       ========

Denominator:

Denominator for basic net earnings per share -
   weighted-average shares outstanding               17,338         15,434

Effect of dilutive securities:
   Stock options                                        873          1,580
                                                    -------       --------


Denominator for diluted net earnings per share -
   adjusted weighted-average shares                  18,211         17,014
                                                    =======       ========

Basic net earnings per share                       $   0.23      $    0.47
                                                    =======       ========

Diluted net earnings per share                     $   0.22      $    0.42
                                                    =======       ========



                                    8 of 16



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
        ----------------------------------------------------------------


Note 4. - Industry Segment Information
- --------------------------------------

     The Company operates in two business  segments that are managed  separately
based on fundamental  differences in operations:  temporary  healthcare staffing
services and therapy program  management.  Therapy program  management  includes
inpatient programs  (including acute  rehabilitation and skilled nursing units),
contract therapy programs and outpatient therapy programs.  All of the Company's
services are provided in the United  States.  Summarized  information  about the
Company's  operations for the three months ended March 31, 2002 and 2001 in each
industry segment is as follows:



                                                   Three Months Ended
                                                        March 31,
                                                    2002         2001
                                                    ----         ----
                                                 (dollars in thousands)
                                                          
Revenues from Unaffiliated Customers
- ------------------------------------
Healthcare staffing                               $ 70,905   $ 74,281
Therapy program management:
   Inpatient                                        31,769     31,057
   Contract therapy                                 23,415     12,340
   Outpatient                                       12,140     13,046
                                                   -------    -------
      Therapy program management total              67,324     56,443
                                                   -------    -------
            Total                                 $138,229   $130,724
                                                   =======    =======

Operating Earnings (Loss) (1)
- -----------------------------
Healthcare staffing                               $ (1,664)  $  3,866
Therapy program management:
   Inpatient                                         6,032      7,302
   Contract therapy                                  1,553        479
   Outpatient                                          631      1,395
                                                   -------    -------
      Therapy program management total               8,216      9,176
                                                   -------    -------
            Total                                 $  6,552   $ 13,042
                                                   =======    =======

(1)  Operating  earnings  for the prior year have been  adjusted  to reflect the
corporate expense allocation methodology being utilized in the current year.

Depreciation and Amortization
- -----------------------------
Healthcare staffing                               $    473   $    769
Therapy program management:
   Inpatient                                         1,047        907
   Contract therapy                                    227        166
   Outpatient                                          178        280
                                                   -------    -------
      Therapy program management total               1,452      1,353
                                                   -------    -------
            Total                                 $  1,925   $  2,122
                                                   =======    =======

Capital Expenditures
- --------------------
Healthcare staffing                               $    177   $    444
Therapy program management:
   Inpatient                                         1,638        960
   Contract therapy                                    904        680
   Outpatient                                          592        584
                                                   -------    -------
      Therapy program management total               3,134      2,224
                                                   -------    -------
            Total                                 $  3,311   $  2,668
                                                   =======    =======


                                    9 of 16


REHABCARE GROUP, INC.

Note 4. - Industry Segment Information, Continued
- -------------------------------------------------


                                                     As of March 31,
                                                    2002         2001
                                                    ----         ----
                                                  (dollars in thousands)
                                                       
Total Assets
- ------------
Healthcare staffing                               $100,775   $110,483
Therapy program management:
   Inpatient                                        95,436     64,314
   Contract therapy                                 30,051     28,181
   Outpatient                                       30,637     31,468
                                                   -------    -------
      Therapy program management total             156,124    123,963
                                                   -------    -------
            Total                                 $256,899   $234,446
                                                   =======    =======


Item 2. -  Management's  Discussion  and  Analysis of  Financial  Condition  and
- --------------------------------------------------------------------------------
Results of Operations
- ---------------------

     This Quarterly Report on Form 10-Q contains forward-looking statements that
are made  pursuant  to the safe  harbor  provisions  of the  Private  Securities
Litigation  Reform Act of 1995.  Forward-looking  statements  involve  known and
unknown risks and  uncertainties  that may cause the Company's actual results in
future periods to differ  materially  from forecasted  results.  These risks and
uncertainties  may  include,  but are not  limited  to,  the  effect of  certain
corrective  actions  already  taken in  supplemental  staffing,  the  timing and
magnitude  of  volume  improvements,  new  program  openings  and  planned  cost
controls, fluctuations in occupancy of the Company's hospital and long-term care
clients,  changes  in  governmental   reimbursement   regulations  or  policies,
inability  to attract  new client  relationships  or to retain  existing  client
relationships, and the ability to attract operational and professional employees
and general economic downturn.

Results of Operations
- ---------------------

     The Company  provides  temporary  healthcare  staffing and therapy  program
management  services for hospitals and long-term  care  facilities.  The Company
derives its revenue from two business segments:  temporary  healthcare  staffing
services and therapy  program  management.  The Company's  temporary  healthcare
staffing  segment  includes  both  supplemental  personnel and travelers who are
typically on 13 week  assignments.  The  Company's  therapy  program  management
segment includes inpatient programs (including acute  rehabilitation and skilled
nursing units), contract therapy programs and outpatient therapy programs.


                                                         Three Months Ended
                                                              March 31,
Operating Statistics:                                     2002         2001
                                                          ----         ----
                                                             
Healthcare staffing:
   Average number of staffing branch offices               112          103
   Number of weeks worked (supplemental and travel)     48,392       59,370
   Average revenue per week worked                    $  1,465     $  1,251

Therapy program management:
Inpatient units (acute rehabilitation and
 skilled nursing):
   Average number of programs                            134.3        138.0
   Average bed capacity                                  2,686        2,724
   Average length of stay (days)                          13.4         13.8
   Patient days                                        185,015      188,576
   Admissions                                           13,767       13,634
   Total programs in operation at end of period            133          138

                                    10 of 16


Contract therapy:
   Average number of locations                           337.1        215.0
   Number of locations at end of period                    351          219
   Average revenue per location                       $ 69,458      $57,394

Outpatient programs:
   Average number of programs                             56.3         64.5
   Patient visits                                      354,297      375,008
   Units of service                                    956,949    1,072,629
   Total programs in operation at end of period             55           65

Three Months Ended March 31, 2002 Compared to Three Months Ended March 31, 2001
- -------------------------------------------------------------------------------

REVENUES

     Operating  revenues  during  the first  quarter of 2002  increased  by $7.5
million,  or 5.7%, to $138.2  million as compared to $130.7 million in operating
revenues  during the first  quarter of 2001.  Increases in contract  therapy and
inpatient were offset by declines in staffing and outpatient.

     Staffing revenue  decreased by 4.5% from $74.3 million in the first quarter
of 2001 to $70.9  million in the first  quarter of 2002.  Supplemental  staffing
revenues  decreased  19.7%  from $57.4  million in the first  quarter of 2001 to
$46.0  million  in the first  quarter  of 2002,  as the  Company  completed  the
implementation in the supplemental staffing division of new software and systems
training,  database  repopulation  and  management  transition  initiated in the
fourth  quarter of 2001.  A 28.1%  decrease  in weeks  worked from 49,247 in the
first  quarter  of 2001 to 35,403 in the first  quarter of 2002 was offset by an
11.7%  increase in average  revenue  per week worked from $1,157 to $1,292.  The
increase  in average  revenue  per week  worked was  primarily  the result of an
increased  focus on placing more RN's and LPN's versus  CNA's.  Travel  staffing
revenues  increased  46.8%  from $16.9  million in the first  quarter of 2001 to
$24.9 million in the first quarter of 2002, reflecting a 28.3% increase in weeks
worked from 10,123 in the first  quarter of 2001 to 12,989 in the first  quarter
of 2002 and a 14.5%  increase in average  revenue per week worked from $1,672 to
$1,914.

     Inpatient program revenue increased by 2.3% from $31.1 million in the first
quarter of 2001 to $31.8  million in the first  quarter of 2002. A 4.3% increase
in revenue per patient  day was offset by a 1.9%  decrease in patient  days from
188,576 to 185,015.  The  decrease in patient  days  primarily  resulted  from a
decrease in the  average  number of  inpatient  programs  managed  from 138.0 to
134.3.  Average length of stay decreased to 13.4. The decrease in average length
of stay was  primarily  a result of the  phase-in  of the  Medicare  prospective
payment   system   ("PPS")   which  began  on  January  1,  2002  for  inpatient
rehabilitation  facilities. As the Company's clients convert to PPS, the Company
is moving to modify the reimbursement in its contracts from primarily a rate per
patient  day to a rate  per  discharge.  This  will  help  align  the  Company's
incentives with its clients.

     Contract therapy revenue increased by 89.7% from $12.3 million in the first
quarter of 2001 to $23.4  million in the first  quarter  of 2002,  reflecting  a
56.8% increase in the average number of contract therapy  locations managed from
215.0 to 337.1,  and a 21.0%  increase in revenue per  location  from $57,394 to
$69,458.  The increase in revenue per  location is primarily  the result of same
store growth and a continued focus on opening larger locations.

     Outpatient  revenue  decreased  by 6.9%  from  $13.0  million  in the first
quarter of 2001 to $12.1  million in the first  quarter  of 2002,  reflecting  a
12.7% decrease in the average number of outpatient programs managed from 64.5 to
56.3,  offset by a 2.3%  increase in units of service per program from 16,630 to
17,006 and a 6.7% increase in the average  revenue per location from $202,250 to
$215,746.

                                    11 of 16


OPERATING EARNINGS

     Consolidated  operating  earnings  decreased by 49.8% from $13.0 million in
the  first  quarter  of 2001 to $6.6  million  in the  first  quarter  of  2002.
Operating expenses as a percentage of revenues increased from 71.2% in the first
quarter  of 2001 to 74.4% in the first  quarter  of 2002,  primarily  reflecting
narrower  spreads between bill and pay rates in the staffing  division and lower
productivity  in  the  therapy   program   management   division.   General  and
administrative  expenses as a percentage of revenue  increased from 17.2% in the
first  quarter of 2001 to 19.5% in the first quarter of 2002.  Depreciation  and
amortization  as a  percentage  of  revenues  decreased  from  1.6% in the first
quarter  of 2001  to  1.4% in the  first  quarter  of  2002 as a  result  of the
elimination of goodwill  amortization  from the adoption of Statement No. 142 on
January  1,  2002.  The  elimination  of  goodwill  amortization  was  offset by
increased  depreciation expense recorded on capital expenditures.  The following
discussion  by division  includes the effect of adjusting  the first  quarter of
2001 operating earnings to reflect the current overhead  allocation method being
utilized in the first quarter of 2002.

     Operating  earnings  (loss)  in the  staffing  division  decreased  by $5.5
million  to a loss of $1.7  million  in the first  quarter  of 2002,  reflecting
significant expenses associated with management reorganization, systems roll-out
and  training,  and a move toward  consolidation  of the  supplemental  staffing
division's  branch   administrative   functions.   As  a  result,   general  and
administrative  expenses as a percentage of revenues increased from 18.8% in the
first quarter of 2001 to 22.8% in the first quarter of 2002. Gross profit margin
decreased  from 26.0% in the first  quarter of 2001 to 22.1% in first quarter of
2002 as a result  of  decreased  productivity  in the  branches  due to  systems
training  and narrower  spreads  between  bill and pay rates.  Depreciation  and
amortization  expense as a  percentage  of revenues  decreased  from 1.0% in the
first  quarter  of 2001 to 0.7% in the first  quarter of 2002 as a result of the
elimination of goodwill amortization from the adoption of Statement No. 142.

     Inpatient operating earnings decreased 17.4% from $7.3 million in the first
quarter of 2001 to $6.0  million  in the first  quarter  of 2002,  reflecting  a
decrease in operating margin from 37.9% to 35.8%, and an increase in general and
administrative  expenses  as a percent  of  revenues  from  11.8% to 13.3%.  The
decrease in operating  margin was primarily the result of lower  productivity in
further  preparing  for the  implementation  of a  prospective  payment  system.
Depreciation and amortization as a percentage of revenues increased from 2.5% in
2001 to 3.3% in 2002, as depreciation on capital  expenditures  more than offset
the elimination of goodwill amortization related to Statement No. 142.

     Contract therapy operating  earnings  increased 224.2% from $0.5 million in
the  first  quarter  of 2001 to $1.6  million  in the  first  quarter  of  2002,
reflecting  an 89.7%  increase in  operating  revenues,  offset by a decrease in
operating  margin  from 31.0% to 27.1% as a result of a high  degree of contract
labor costs  associated  with the large  number of programs  added.  General and
administrative  expenses as a  percentage  of revenues  decreased  from 23.7% to
18.0%.  Depreciation  and  amortization  expense  as a  percentage  of  revenues
decreased from 1.8% in the first quarter of 2001 to 1.0% in the first quarter of
2002,  reflecting the  elimination of goodwill  amortization  expense related to
Statement No. 142.

     Outpatient  operating  earnings  decreased  54.8% from $1.4  million in the
first quarter of 2001 to $0.6 million in the first quarter of 2002, reflecting a
decrease in operating  margin from 28.5% to 25.8% as a result of increased labor
expenses and an increase in general and administrative  expenses as a percentage
of revenues  from 15.3% to 18.8%.  Depreciation  and  amortization  expense as a
percentage of revenues  decreased from 2.6% in 2001 to 1.5% in 2002,  reflecting
the elimination of goodwill amortization expense related to Statement No. 142.

                                    12 of 16

NONOPERATING ITEMS

     Interest  income  increased  by  $44,000  or 71.0% to $0.1  million  due to
increased cash balances.

     Interest  expense  decreased  by $1.0 million or 86.1% from $1.2 million in
the  first  quarter  of 2001 to $0.2  million  in the  first  quarter  of  2002,
primarily  reflecting the repayment of the line of credit debt during March 2001
and the repayment of all subordinated debt during the fourth quarter 2001.

     Earnings  before income taxes  decreased by $5.4 million from $11.9 million
in the first quarter of 2001 to $6.5 million in the first  quarter of 2002.  The
provision  for  income  taxes in the  first  quarter  of 2001  was $4.7  million
compared  to $2.5  million in the first  quarter of 2002,  reflecting  effective
income tax rates of 39.8% and 38.0%,  respectively.  Net  earnings  decreased by
$3.2 million,  or 43.9%,  to $4.0 million in the first quarter of 2002 from $7.2
million in the first quarter of 2001.  Diluted net earnings per share  decreased
by 47.6% from $0.42 in the first  quarter of 2001 to $0.22 in the first  quarter
of 2002 on a 7.0%  increase  in the  weighted-average  shares  outstanding.  The
increase in the weighted-average  shares outstanding was attributable  primarily
to the secondary  equity offering during March 2001, and stock option grants and
exercises.


Liquidity and Capital Resources
- -------------------------------

     As of March 31, 2002,  the Company had $26.5 million in cash and short-term
investments and a current ratio, the amount of current assets divided by current
liabilities,  of 2.7 to 1.  Working  capital  increased by $2.4 million to $80.0
million as of March 31, 2002, compared to $77.5 million as of December 31, 2001.
The increase in working  capital is primarily due to working  capital  generated
from operations.

     Net accounts  receivable were $88.3 million at March 31, 2002,  compared to
$91.4  million at December 31, 2001.  The number of days' average net revenue in
net  receivables  was 56.5 at March 31,  2002,  it's lowest point in almost four
years, compared to 63.8 at December 31, 2001.

     The  Company's  operating  cash  flows  constitute  its  primary  source of
liquidity and  historically  have been  sufficient to fund its working  capital,
capital expenditures, internal business expansion and debt service requirements.
The Company expects to meet its future working  capital,  capital  expenditures,
internal and external  business  expansion and debt service  requirements from a
combination of internal sources and outside financing.  The Company has a $125.0
million  revolving  line of  credit  expiring  in August  2005  with no  balance
outstanding as of March 31, 2002, and no other debt obligation.


Part II. - Other Information
- ----------------------------


Item 1 - Legal Proceedings
- --------------------------

     The Company is subject to various  claims and legal actions in the ordinary
course of business.  These matters  include,  without  limitation,  professional
liability,   employee-related   matters  and  inquiries  and  investigations  by
governmental  agencies relating to Medicare or Medicaid  reimbursement and other
issues.

     The Company recently reached a settlement  agreement with the United States
Department  of Labor under which the Company has  conducted a self-audit  of the
overtime  practices for certain  temporary  employees of the Company's  staffing
division for the period from January 1, 1998 to October 26, 2001.

                                    13 of 16



In order to implement the agreement, the Department of Labor recently filed suit
against the Company and certain of the Company's  subsidiaries  in federal court
in St. Louis,  Missouri and a pre-negotiated  order was approved by the court on
November 2, 2001 (the "Order").  The suit serves to bar future multiple suits on
the overtime  compensation  issue for the time period  covered by the Order with
respect to the employees covered by the Order, and the time period for the audit
has been extended by agreement to December 31, 2001.  Pursuant to the Order, the
Company  conducted a review of personnel  records.  Based upon such  review,  in
April 2002 the Company  submitted a report to the Department of Labor indicating
whether  each  individual  employed  as a temporary  employee  of the  Company's
staffing  division  during  the  period  under  audit  was or was not  owed  any
additional overtime compensation. This report is currently being reviewed by the
Department  of Labor.  In the fourth  quarter of 2001,  the  Company  reported a
non-recurring  charge of  approximately  $6 million relating to costs associated
with these overtime payments, including the associated costs of the audit. While
the Company believes the $6 million will be adequate to cover these payments and
costs, the actual total expenses incurred in this matter may be higher or lower.
The Company expects these payments to be made during the second quarter of 2002.

     In  addition,   the  Company's   clients  may  become  subject  to  claims,
governmental inquiries and investigations and legal actions to which the Company
may become a party  relating to services  provided by the Company.  From time to
time and depending on the particular facts and circumstances, the Company may be
subject to  indemnification  obligations under the Company's  contracts with the
Company's clients relating to these matters. The Company has recently received a
formal demand for  indemnification by the current owner of a client facility for
liabilities,  including  attorneys'  fees and expenses,  arising out of a recent
assessment of liability  communicated by the United States Department of Justice
to the Company's client for settlement  purposes.  The Department's claim is the
result of its  investigation  of alleged  improper  billing  practices under the
Medicare program relating to an inpatient  rehabilitation  unit that the Company
manages at the client  facility.  The Company has denied any liability under the
indemnification  provisions of the Company's  contract with the client  facility
based upon its belief that the alleged  inaccuracies  in the billing process for
Medicare  patients  were  not the  result  of any of the  Company's  actions  or
omissions  in  operating  the  rehabilitation  unit.  At no time was the Company
responsible,  either contractually or otherwise,  for the client facility's cost
reporting for Medicare  patients,  nor does the Company  believe that any of the
clinical information that the Company provided to the client facility formed the
basis for the allegedly inaccurate cost reporting. The Company is not a party to
the  Department of Justice's  claim against the client  facility and the Company
has  declined  its client's  offer to be a party to the  settlement  discussions
based  upon  the  Company's  belief  that  the  Company  has no  indemnification
liability on this claim.


Item 4 - Submission of Matters to Security Holders
- --------------------------------------------------

     The annual  Meeting of  Stockholders  of the Company was held on Wednesday,
May 1, 2002, at which time the  stockholders  voted to elect the seven incumbent
directors to hold office until the next annual  meeting of  stockholders  of the
Company or until their  successors  have been duly  elected and  qualified.  The
names of each of the  directors of the Company who were  reelected at the Annual
Meeting and the votes cast "FOR" or for which  authority to vote was  "WITHHELD"
is as follows:

                                                  
      Name                             For              Withheld Authority
      ----                             ---              ------------------

      William G. Anderson           14,772,808                134,975
      Colleen Conway-Welch          14,772,840                134,943
      Alan C. Henderson             13,083,296              1,824,487
      Richard E. Ragsdale           14,773,253                134,530
      John H. Short                 14,774,063                133,720
      H. Edwin Trusheim             14,766,918                140,865
      Theodore M. Wight             14,771,573                136,210


                                    14 of 16

Item 6 - Exhibits and Reports on Form 8-K
- -----------------------------------------

    (a)  Exhibits

         None

    (b)  Reports on Form 8-K

         None

                                    15 of 16





                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                                   REHABCARE GROUP, INC.

May 10, 2002

                                                   By:/s/  Gregory J. Eisenhauer
                                                     ---------------------------
                                                           Gregory J. Eisenhauer
                                                       Senior Vice President and
                                                         Chief Financial Officer


                                                   By:/s/      James M. Douthitt
                                                      --------------------------
                                                               James M. Douthitt
                                                       Senior Vice President and
                                                        Chief Accounting Officer

                                    16 of 16